Lanreotide

Is Lanreotide legal in the US?

Yes, FDA approved for acromegaly, certain gut tumors and carcinoid syndrome.

Approved. Lanreotide is marketed in the US as Somatuline Depot for acromegaly (first approved 2007), for unresectable or metastatic gastroenteropancreatic neuroendocrine tumors, and for carcinoid syndrome. A therapeutically equivalent lanreotide injection from Cipla is also approved. ²

Read the full Lanreotide page

Reference information only, not medical advice. Drawn from the Lanreotide article, fact-checked against the cited sources. No dosing anywhere on this site.